U.S. pharmaceutical packaging industry worth $18.5 billion by 2014: report

Demand for pharmaceutical packaging in the U.S. is forecast to increase 5.3 per cent annually to US$18.5 billion in 2014, according to a new study by market research firm The Freedonia Group.  

“Recently upgraded regulations and standards that address such issues as barrier protection, infection control, patient drug compliance, drug dispensing errors, and drug diversion and counterfeiting will boost demand for high value-added containers and accessories,” the company’s “Pharmaceutical Packaging” study said. ”Enhanced barrier plastic bottles, calendar and wallet blister packaging, prefillable syringes and inhalers, authentication labels and unit dose pouches [will all be in demand].”

The fastest growth is anticipated for prefillable syringes, which will expand applications as advances in biotechnology lead to the introduction of new therapies that must be injected, the study concluded. The market for pharmaceutical pouches will also expand at a fast pace, spurred by increasing applications in the unit dose packaging of transdermal patches, powders for reconstitution, and topical creams and ointments. 

For more information on the “Pharmaceutical Packaging” report, click on this link.